LBF20207PG41: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=XPR1772 | |LipidBank=XPR1772 | ||
|LipidMaps=LMFA03010102 | |LipidMaps=LMFA03010102 | ||
|SysName= | |SysName=9alpha,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid | ||
|Common Name=&&15 (R) -Prostaglandin D_2&& | |Common Name=&&15 (R) -Prostaglandin D_2&&9alpha,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= |
Revision as of 06:17, 19 January 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1772 |
LipidMaps | LMFA03010102 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG41 |
15 (R) -Prostaglandin D2 | |
---|---|
Structural Information | |
9α,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC |
Physicochemical Information | |
15(R)-PGD2 is reported to have potent agonistic effect to the DP2 receptor 5 time higher than PGD2. Giles_H et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|